Business Description
Hemostemix Inc
NAICS : 325412
SIC : 3741
ISIN : CA4236943060
Compare
Compare
Traded in other countries / regions
HEM.CanadaHMTXF.USA2VF0.Germany IPO Date
2021-04-01Description
Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | -34.25 | |||||
| Debt-to-Equity | -0.55 | |||||
| Debt-to-EBITDA | -4.8 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 53.5 | |||||
| 3-Year EPS without NRI Growth Rate | 48 | |||||
| 3-Year FCF Growth Rate | 54.9 | |||||
| 3-Year Book Growth Rate | -62 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 70.8 | |||||
| 9-Day RSI | 65.24 | |||||
| 14-Day RSI | 60.67 | |||||
| 6-1 Month Momentum % | -58.24 | |||||
| 12-1 Month Momentum % | -74.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.07 | |||||
| Quick Ratio | 0.07 | |||||
| Cash Ratio | 0.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.2 | |||||
| Shareholder Yield % | -29.32 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -12.4 | |||||
| EV-to-EBITDA | -12.4 | |||||
| EV-to-FCF | -8.4 | |||||
| Earnings Yield (Greenblatt) % | -8.06 | |||||
| FCF Yield % | -19.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hemostemix Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.01 | ||
| Beta | 1.27 | ||
| Volatility % | 92.18 | ||
| 14-Day RSI | 60.67 | ||
| 14-Day ATR (€) | 0.002488 | ||
| 20-Day SMA (€) | 0.026175 | ||
| 12-1 Month Momentum % | -74.67 | ||
| 52-Week Range (€) | 0.019 - 0.0825 | ||
| Shares Outstanding (Mil) | 87.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hemostemix Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hemostemix Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hemostemix Inc Frequently Asked Questions
What is Hemostemix Inc(FRA:2VF0)'s stock price today?
The current price of FRA:2VF0 is €0.03. The 52 week high of FRA:2VF0 is €0.08 and 52 week low is €0.02.
When is next earnings date of Hemostemix Inc(FRA:2VF0)?
The next earnings date of Hemostemix Inc(FRA:2VF0) is .
Does Hemostemix Inc(FRA:2VF0) pay dividends? If so, how much?
Hemostemix Inc(FRA:2VF0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers